LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (NASDAQ: CBRX) will hold a conference call on January 4, 2007 to discuss its recent acquisition of the U.S. marketing rights to CRINONE® (progesterone gel). Robert S. Mills, Columbia’s president and chief executive officer, will host the call.
